Evidence map›Paper›PMID 34066804›Full record

ReviewInternational journal of molecular sciences2021

Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?

Naoki Yamamoto, Rain Yamamoto, Yasuo Ariumi, Masashi Mizokami, Kunitada Shimotohno, Hiroshi Yoshikura

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Genetic variants inFrontiers in genetics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency.International journal of chronic obstructive pulmonary disease · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Naoki YamamotoGenome Medical Sciences Project, National Center for Global Health and Medicine, Ichikawa 272-8516, Japan.
Rain YamamotoDepartment of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan.
Yasuo AriumiDivision of Retroelement, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.ORCID 0000-0002-3109-9678
Masashi MizokamiGenome Medical Sciences Project, National Center for Global Health and Medicine, Ichikawa 272-8516, Japan.
Kunitada ShimotohnoGenome Medical Sciences Project, National Center for Global Health and Medicine, Ichikawa 272-8516, Japan.
Hiroshi YoshikuraNational Institute of Infectious Diseases, Tokyo 162-8640, Japan.
National Center for Global Health and Medicine · JPKeio University · JPKumamoto University · JPNational Institute of Infectious Diseases · JP

Funding

Japan Agency for Medical Research and Development JP19fk0108104
6 · The paper itself

Abstract

The elderly and patients with several comorbidities experience more severe cases of coronavirus disease 2019 (COVID-19) than healthy patients without underlying medical conditions. However, it is unclear why these people are prone to developing alveolar pneumonia, rapid exacerbations, and death. Therefore, we hypothesized that people with comorbidities may have a genetic predisposition that makes them more vulnerable to various factors; for example, they are likely to become more severely ill when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To test this hypothesis, we searched the literature extensively. Polymorphisms of genes, such as those that encode angiotensin-converting enzyme 1 (

Indexed as

Genetic Predisposition to DiseaseAgedAllelesAngiotensin-Converting Enzyme 2AnimalsComorbidityCOVID-19HaplotypesHLA AntigensHumansInflammationNeanderthalsPeptidyl-Dipeptidase APolymorphism, GeneticRisk FactorsSeverity of Illness IndexACE2 protein, humanAngiotensin-Converting Enzyme 2HLA AntigensPeptidyl-Dipeptidase AAAT deficiencyACE1 DD genotypeACE2ADAM17aggravationAng IIcomorbiditiesCOVID-19inflammationRAASSARS-CoV-2

Identifiers

PMID34066804
PMCPMC8125927
OpenAlexW3163904095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.